Literature DB >> 9874770

Mechanisms by which IkappaB proteins control NF-kappaB activity.

S Simeonidis1, D Stauber, G Chen, W A Hendrickson, D Thanos.   

Abstract

The biological activity of the transcription factor NF-kappaB is differentially controlled by three IkappaB proteins, Ikappa Balpha, Ikappa Bbeta, and Ikappa Bepsilon. We have examined the molecular basis for the differential inhibitory strengths of IkappaB proteins by constructing hybrid IkappaBs and found that the first ankyrin repeat of Ikappa Balpha is responsible for its strong inhibitory effect. Swapping a putative beta-turn within the first ankyrin repeat between the strong Ikappa Balpha and the weak IkappaBbeta inhibitors switches their in vivo inhibitory activity on NF-kappaB. The qualitatively distinct contacts made by this beta-turn in Ikappa Balpha and Ikappa Bbeta with NF-kappaB determine the efficiency by which IkappaBs sequester NF-kappaB to the cytoplasm, thus explaining their distinct effects on gene activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9874770      PMCID: PMC15091          DOI: 10.1073/pnas.96.1.49

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

Review 1.  Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation.

Authors:  I M Verma; J K Stevenson; E M Schwarz; D Van Antwerp; S Miyamoto
Journal:  Genes Dev       Date:  1995-11-15       Impact factor: 11.361

2.  Role of unphosphorylated, newly synthesized I kappa B beta in persistent activation of NF-kappa B.

Authors:  H Suyang; R Phillips; I Douglas; S Ghosh
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

3.  NF-kappa B: ten years after.

Authors:  P A Baeuerle; D Baltimore
Journal:  Cell       Date:  1996-10-04       Impact factor: 41.582

Review 4.  The NF-kappa B and I kappa B proteins: new discoveries and insights.

Authors:  A S Baldwin
Journal:  Annu Rev Immunol       Date:  1996       Impact factor: 28.527

5.  Structure of the p53 tumor suppressor bound to the ankyrin and SH3 domains of 53BP2.

Authors:  S Gorina; N P Pavletich
Journal:  Science       Date:  1996-11-08       Impact factor: 47.728

6.  IkappaBalpha deficiency results in a sustained NF-kappaB response and severe widespread dermatitis in mice.

Authors:  J F Klement; N R Rice; B D Car; S J Abbondanzo; G D Powers; P H Bhatt; C H Chen; C A Rosen; C L Stewart
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

7.  Basal phosphorylation of the PEST domain in the I(kappa)B(beta) regulates its functional interaction with the c-rel proto-oncogene product.

Authors:  Z L Chu; T A McKinsey; L Liu; X Qi; D W Ballard
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

Review 8.  NF-kappa B: a lesson in family values.

Authors:  D Thanos; T Maniatis
Journal:  Cell       Date:  1995-02-24       Impact factor: 41.582

9.  Constitutive NF-kappa B activation, enhanced granulopoiesis, and neonatal lethality in I kappa B alpha-deficient mice.

Authors:  A A Beg; W C Sha; R T Bronson; D Baltimore
Journal:  Genes Dev       Date:  1995-11-15       Impact factor: 11.361

10.  I kappa B-beta regulates the persistent response in a biphasic activation of NF-kappa B.

Authors:  J E Thompson; R J Phillips; H Erdjument-Bromage; P Tempst; S Ghosh
Journal:  Cell       Date:  1995-02-24       Impact factor: 41.582

View more
  30 in total

1.  Thiocolchicoside exhibits anticancer effects through downregulation of NF-κB pathway and its regulated gene products linked to inflammation and cancer.

Authors:  Simone Reuter; Sahdeo Prasad; Kanokkarn Phromnoi; Jayaraj Ravindran; Bokyung Sung; Vivek R Yadav; Ramaswamy Kannappan; Madan M Chaturvedi; Bharat B Aggarwal
Journal:  Cancer Prev Res (Phila)       Date:  2010-10-26

2.  Regulation of constitutive p50/c-Rel activity via proteasome inhibitor-resistant IkappaBalpha degradation in B cells.

Authors:  Shelby O'Connor; Stuart D Shumway; Ian J Amanna; Colleen E Hayes; Shigeki Miyamoto
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

3.  3-Formylchromone interacts with cysteine 38 in p65 protein and with cysteine 179 in IκBα kinase, leading to down-regulation of nuclear factor-κB (NF-κB)-regulated gene products and sensitization of tumor cells.

Authors:  Vivek R Yadav; Sahdeo Prasad; Subash C Gupta; Bokyung Sung; Sharangdhar S Phatak; Shuxing Zhang; Bharat B Aggarwal
Journal:  J Biol Chem       Date:  2011-11-07       Impact factor: 5.157

4.  Gambogic acid, a novel ligand for transferrin receptor, potentiates TNF-induced apoptosis through modulation of the nuclear factor-kappaB signaling pathway.

Authors:  Manoj K Pandey; Bokyung Sung; Kwang Seok Ahn; Ajaikumar B Kunnumakkara; Madan M Chaturvedi; Bharat B Aggarwal
Journal:  Blood       Date:  2007-08-02       Impact factor: 22.113

5.  NF-kappaB activation during Rickettsia rickettsii infection of endothelial cells involves the activation of catalytic IkappaB kinases IKKalpha and IKKbeta and phosphorylation-proteolysis of the inhibitor protein IkappaBalpha.

Authors:  Dawn R Clifton; Elena Rydkina; Robert S Freeman; Sanjeev K Sahni
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

6.  Regulation and function of nuclear IκBα in inflammation and cancer.

Authors:  Ivana Vancurova; Ales Vancura
Journal:  Am J Clin Exp Immunol       Date:  2012-05-25

7.  Noscapine, a benzylisoquinoline alkaloid, sensitizes leukemic cells to chemotherapeutic agents and cytokines by modulating the NF-kappaB signaling pathway.

Authors:  Bokyung Sung; Kwang Seok Ahn; Bharat B Aggarwal
Journal:  Cancer Res       Date:  2010-03-30       Impact factor: 12.701

8.  The inhibitory effect of alendronate, a nitrogen-containing bisphosphonate on the PI3K-Akt-NFkappaB pathway in osteosarcoma cells.

Authors:  Ryosuke Inoue; Nori-aki Matsuki; Gao Jing; Takashi Kanematsu; Kihachiro Abe; Masato Hirata
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

9.  Effects of IkappaBalpha and its mutants on NF-kappaB and p53 signaling pathways.

Authors:  Xian Li; Da Xing; Ju Wang; De-Bin Zhu; Lan Zhang; Xiao-Jia Chen; Fen-Yong Sun; An Hong
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

10.  Effects of alanyl-glutamine dipeptide on the expression of colon-inflammatory mediators during the recovery phase of colitis induced by dextran sulfate sodium.

Authors:  Yu-Chen Hou; Chia-Chou Chu; Tsui-Ling Ko; Chiu-Li Yeh; Sung-Ling Yeh
Journal:  Eur J Nutr       Date:  2012-07-31       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.